| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0314c17f8ea3bab5fd7bba8cdda11ac2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_afd115dec46c157d3739020ebd4d866b |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y301-06013
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-465
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-16 |
| filingDate |
2015-07-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2016-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_816dd9a8e50b28694ae6ea9b7ec9200d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_54362b9340e428cb533e068d3864016d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1dd0c06a6c749ec1eba84aec8c868fda
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3d5e7fa8cd2b224017ceccf79d4b8938
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4979476c16790f5115624d80017599af
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0f47d5d6db8fe3a6681c0fa269347ce4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_19158658730dac0ec7de61c55f6ca355
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9debd4afc2cac6247468a924a6c8fbb1 |
| publicationDate |
2016-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-9249397-B2 |
| titleOfInvention |
Composition and formulation comprising recombinant human iduronate-2-sulfatase and preparation method thereof |
| abstract |
Disclosed are a composition comprising recombinant iduronate-2-sulfatase (IDS) and a method for treating Hunter syndrome. The glycosylation pattern and formylglycine content of the IDS composition are different from those of ELAPRASE® and have superior pharmaceutical efficacy and are safer than the conventional agent and thus can be effectively used for the therapy of Hunter syndrome. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9896672-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2018112199-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10174299-B2 |
| priorityDate |
2011-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |